The Risk Odds Ratio (ROR) (95% CI) of AF induced by osimertinib was 4.0 (2.8–5.8) compared to all other drugs in FAERS and 2.1 (1.3–3.5) compared to other EGFR-TKIs. Here, EGFR is linked to atrial fibrillation.